CDT Equity CEO Buys Shares Amid Volatility: A Sign of Strategic Rebalancing?
CDT Equity CEO Regan Andrew’s recent insider buys signal a strategic rebalancing amid biotech volatility, hinting at future partnership and pipeline gains.
4 minutes to read